Bornaprine

DB13619InvestigationalSmall molecule

Bornaprine is an anticholinergic drug indicated in the treatment of hyperhidrosis, dyskinesia, akathisia, parkinsonism, and Parkinson's disease. A medication used to treat severe sweating, movement disorders, and Parkinson's disease.

Formula / weight: C₂₁H₃₁NO₂ · 329.484 g/mol (avg)

Resolves to

Compound

UNII9M363FGA7JCAS20448-86-6ChEMBLCHEMBL2104596

Clinical / RWD

RxNorm19610ATCN04AA11

Structure

InChIKeyBDNMABJZSXTKAQ-VCPDFFEISA-NSMILESCCN(CC)CCCOC(=O)C1(C[C@@H]2CC[C@H]1C2)C1=CC=CC=C1

What you can answer from here — as of August 30, 2026

553Drug interactionsStructured to mechanism, not free text

3Structured indicationsCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

29Marketed productsAcross 4 countries and 2 labellers

1ATC codeIncluding every combination product, plus 8 drug categories

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Bornaprine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account